Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics, Inc. (LXEO) FCF Margin (2023)

Lexeo Therapeutics' FCF Margin history spans 2 years, with the latest figure at 27962.0% for Q4 2023.

  • For Q4 2023, FCF Margin fell 406022.0% year-over-year to 27962.0%; the TTM value through Dec 2023 reached 29046.83%, changed N/A, while the annual FY2024 figure was 59234.31%, 3018748.0% up from the prior year.
  • FCF Margin for Q4 2023 was 27962.0% at Lexeo Therapeutics, up from 26846.15% in the prior quarter.
  • Across five years, FCF Margin topped out at 36772.0% in Q1 2023 and bottomed at 24941.51% in Q2 2023.